Spider-Venom Peptides: Structure, Bioactivity, Strategy, and Research Applications
Affiliations
Spiders (Araneae), having thrived for over 300 million years, exhibit remarkable diversity, with 47,000 described species and an estimated 150,000 species in existence. Evolving with intricate venom, spiders are nature's skilled predators. While only a small fraction of spiders pose a threat to humans, their venoms contain complex compounds, holding promise as drug leads. Spider venoms primarily serve to immobilize prey, achieved through neurotoxins targeting ion channels. Peptides constitute a major part of these venoms, displaying diverse pharmacological activities, and making them appealing for drug development. Moreover, spider-venom peptides have emerged as valuable tools for exploring human disease mechanisms. This review focuses on the roles of spider-venom peptides in spider survival strategies and their dual significance as pharmaceutical research tools. By integrating recent discoveries, it provides a comprehensive overview of these peptides, their targets, bioactivities, and their relevance in spider survival and medical research.
Venoms and Extracellular Vesicles: A New Frontier in Venom Biology.
Bala A, Oukkache N, Sanchez E, Suntravat M, Galan J Toxins (Basel). 2025; 17(1).
PMID: 39852989 PMC: 11769160. DOI: 10.3390/toxins17010036.
Oh J, Shin M, Park H, Kim S, Lee B, Yoo J Antibiotics (Basel). 2025; 13(12.
PMID: 39766503 PMC: 11672609. DOI: 10.3390/antibiotics13121113.
Identification and Evolutionary Analysis of the Widely Distributed CAP Superfamily in Spider Venom.
Jiang H, Wang Y, Zhang G, Jia A, Wei Z, Wang Y Toxins (Basel). 2024; 16(6).
PMID: 38922134 PMC: 11209345. DOI: 10.3390/toxins16060240.
Analgesic Peptides: From Natural Diversity to Rational Design.
Gach-Janczak K, Biernat M, Kuczer M, Adamska-Bartlomiejczyk A, Kluczyk A Molecules. 2024; 29(7).
PMID: 38611824 PMC: 11013236. DOI: 10.3390/molecules29071544.